Florian Tilquin
Research Subjects
Florian Tilquin has a total of 12 co-authors. Here are the top co-authors by number of shared publications:
- Alexis Bisiaux
Biosency, 35510 Cesson-Sévigné, France
1 shared publication - Aline Taoum
Laboratoire Traitement du Signal et de l’Image (LTSI-Inserm UMR 1099), Université de Rennes 1, 35042 Rennes, France
1 shared publication - Guy Carrault
Univ Rennes, Inserm, LTSI - UMR 1099, Rennes, France
1 shared publication Jean-Charles Dron
4eMeuse Santé, Bar-le-Duc, France
1 shared publicationJean-Claude Cornu
Hôpital de Verdun, Verdun, France
1 shared publicationJean-Louis Pépin
HP2 Laboratory, Inserm U1300, Grenoble Alpes University, Grenoble, France
1 shared publication
Latest Publications
- 14 September 2024
- Published by European Respiratory Society (ERS) in European Respiratory Journal
- Vol. 64 (suppl 68) , PA378
AECOPD prediction through a remote monitoring system
Rationale: Early identification of Acute Exacerbation is a crucial issue in COPD management. Promising results from Remote Patient Monitoring (RPM) suggest it could be a game changer in the field. The aim of the study was to assess performances of a predictive scoring model fed by longitudinal data collected through a RPM system. Methods: In a six-month prospective study, COPD patients were monitored using Bora band® wristband (BiosencyTM, France). This device remotely collected SpO2, Heart Rate (HR), and Breath Rate (BR), while Acute Exacerbation of COPD (AECOPD) identification and severity characterization were done at 3- and 6-month follow-up visits. Each vital sign time serie was stochastically prefiltered, Z-scored and aggregated into a single score called BVS3 ® (BORA Vital Sign Standard Score). Results: Over a 6-month monitoring period, we included 158 COPD patients (GOLD grade: 16% I, 48% II, 22% III, 14% IV) with a mean age of 63.3 years (SD 8.1 years) with a M/F gender ratio of 1.5. Patients wore wristbands 66% to 99% of the time (mean 87%, SD 9%). We collected an average of 31.9 SpO2, 58.8 HR, and 39.9 BR measures per day. A total of 29 AECOPD (25 moderate, 4 severe) were recorded. BVS3 score predicted exacerbations 4.4 days before onset validated by clinicians (SD 4.3), exhibiting sensitivity (86.2%) and specificity (84.6%), with an AUC of 0.93. Conclusion: Patients had an excellent acceptance of Bora band® leading to collection of more than 130 vital signs daily. The specificity, sensitivity, and anticipation of our BVS3 patient specific AECOPD early detection scoring is very promising for enhancing COPD management.
- 14 September 2024
- Published by European Respiratory Society (ERS) in European Respiratory Journal
- Vol. 64 (suppl 68) , PA378
AECOPD prediction through a remote monitoring system
Rationale: Early identification of Acute Exacerbation is a crucial issue in COPD management. Promising results from Remote Patient Monitoring (RPM) suggest it could be a game changer in the field. The aim of the study was to assess performances of a predictive scoring model fed by longitudinal data collected through a RPM system. Methods: In a six-month prospective study, COPD patients were monitored using Bora band® wristband (BiosencyTM, France). This device remotely collected SpO2, Heart Rate (HR), and Breath Rate (BR), while Acute Exacerbation of COPD (AECOPD) identification and severity characterization were done at 3- and 6-month follow-up visits. Each vital sign time serie was stochastically prefiltered, Z-scored and aggregated into a single score called BVS3 ® (BORA Vital Sign Standard Score). Results: Over a 6-month monitoring period, we included 158 COPD patients (GOLD grade: 16% I, 48% II, 22% III, 14% IV) with a mean age of 63.3 years (SD 8.1 years) with a M/F gender ratio of 1.5. Patients wore wristbands 66% to 99% of the time (mean 87%, SD 9%). We collected an average of 31.9 SpO2, 58.8 HR, and 39.9 BR measures per day. A total of 29 AECOPD (25 moderate, 4 severe) were recorded. BVS3 score predicted exacerbations 4.4 days before onset validated by clinicians (SD 4.3), exhibiting sensitivity (86.2%) and specificity (84.6%), with an AUC of 0.93. Conclusion: Patients had an excellent acceptance of Bora band® leading to collection of more than 130 vital signs daily. The specificity, sensitivity, and anticipation of our BVS3 patient specific AECOPD early detection scoring is very promising for enhancing COPD management.
- Open Access
Validity of Ultra-Short-Term HRV Analysis Using PPG—A Preliminary Study
Continuous measurement of heart rate variability (HRV) in the short and ultra-short-term using wearable devices allows monitoring of physiological status and prevention of diseases. This study aims to evaluate the agreement of HRV features between a commercial device (Bora Band, Biosency) measuring photoplethysmography (PPG) and reference electrocardiography (ECG) and to assess the validity of ultra-short-term HRV as a surrogate for short-term HRV features. PPG and ECG recordings were acquired from 5 healthy subjects over 18 nights in total. HRV features include time-domain, frequency-domain, nonlinear, and visibility graph features and are extracted from 5 min 30 s and 1 min 30 s duration PPG recordings. The extracted features are compared with reference features of 5 min 30 s duration ECG recordings using repeated-measures correlation, Bland–Altman plots with 95% limits of agreements, Cliff’s delta, and an equivalence test. Results showed agreement between PPG recordings and ECG reference recordings for 37 out of 48 HRV features in short-term durations. Sixteen of the forty-eight HRV features were valid and retained very strong correlations, negligible to small bias, with statistical equivalence in the ultra-short recordings (1 min 30 s). The current study concludes that the Bora Band provides valid and reliable measurement of HRV features in short and ultra-short duration recordings.
Open AccessValidity of Ultra-Short-Term HRV Analysis Using PPG—A Preliminary Study
Continuous measurement of heart rate variability (HRV) in the short and ultra-short-term using wearable devices allows monitoring of physiological status and prevention of diseases. This study aims to evaluate the agreement of HRV features between a commercial device (Bora Band, Biosency) measuring photoplethysmography (PPG) and reference electrocardiography (ECG) and to assess the validity of ultra-short-term HRV as a surrogate for short-term HRV features. PPG and ECG recordings were acquired from 5 healthy subjects over 18 nights in total. HRV features include time-domain, frequency-domain, nonlinear, and visibility graph features and are extracted from 5 min 30 s and 1 min 30 s duration PPG recordings. The extracted features are compared with reference features of 5 min 30 s duration ECG recordings using repeated-measures correlation, Bland–Altman plots with 95% limits of agreements, Cliff’s delta, and an equivalence test. Results showed agreement between PPG recordings and ECG reference recordings for 37 out of 48 HRV features in short-term durations. Sixteen of the forty-eight HRV features were valid and retained very strong correlations, negligible to small bias, with statistical equivalence in the ultra-short recordings (1 min 30 s). The current study concludes that the Bora Band provides valid and reliable measurement of HRV features in short and ultra-short duration recordings.